Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy

Region Skane1 site in 1 country400 target enrollmentOctober 2013

ConditionsDermatitis, Allergic Contact

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Dermatitis, Allergic Contact
Sponsor: Region Skane
Enrollment: 400
Locations: 1
Primary Endpoint: knowledge
Status: Completed
Last Updated: 9 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to determine whether extended information given to patients with contact allergy improves knowledge, treatment efficacy and daily functioning.

Registry

clinicaltrials.gov

Start Date

October 2013

End Date

September 2016

Last Updated

9 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Region Skane

Responsible Party

Principal Investigator

Andreas Sonesson

MD PhD

Region Skane

Eligibility Criteria

Inclusion Criteria

•Patients with suspected contact allergy
•Age above 18 years
•Participants have given informed consent

Exclusion Criteria

•Mental or language disabilities

Outcomes

Primary Outcomes

knowledge

Time Frame: one year after inclusion

knowledge about specific contact allergies and exposure, assessed by questionnaire, a modified version of Nordic Occupational Skin Questionnaire NOSQ-2002/Long, and patient records.